Quantcast
Last updated on April 21, 2014 at 7:52 EDT

Latest Novo Nordisk Stories

2013-12-11 23:22:41

ChinaMarketResearchReports.com adds “Global and China Insulin Industry Report, 2013-2017” latest report to its store. Dallas, TX (PRWEB) December 11, 2013 As the third largest human health disease following neoplastic disease, cardiovascular and cerebrovascular diseases, the number of diabetic patients has continued growing from 246 million in 2007 to 382 million in 2013 at a compound annual growth rate of 7.6%. And insulin as the important diabetes medication has also seen increasing...

2013-12-05 23:04:28

Reportbuyer.com just published a new market research report: Drug Delivery Partnering Terms and Agreements. London (PRWEB) December 05, 2013 The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals....

2013-12-05 04:20:58

MELBOURNE, Australia, December 5, 2013 /PRNewswire/ -- Results from the global Diabetes Attitudes, Wishes and Needs 2 study (DAWN2(TM)) presented today at a symposium during the World Diabetes Congress of the International Diabetes Federation (IDF), show that only 29% of people with diabetes report that their healthcare team ask for their input when making their treatment plans. Furthermore, only 33% said they were encouraged by their healthcare professional to ask questions...

2013-12-02 20:22:24

COPENHAGEN, Denmark, December 2, 2013 /PRNewswire/ -- Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg(R) compared to biphasic...

2013-11-21 23:20:21

Reportbuyer.com just published a new market research report: Analysis of the Global Type 2 Diabetes Therapeutics Market. London (PRWEB) November 21, 2013 Market Opportunities for Differentiated Therapeutics Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a vast and growing pipeline of potential new therapies aimed at the unmet needs of tighter glucose control, improved safety profiles, and...

2013-11-05 23:19:04

Reportbuyer.com just published a new market research report: Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013 London (PRWEB) November 05, 2013 Summary GlobalData's clinical trial report, “Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013" provides data on the Pre-Diabetes/Impaired Glucose Tolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on...

2013-11-04 16:26:22

DUBLIN, November 4, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/d8qj9s/european) has announced the addition of the "European Injectable Drug Delivery - Market Forecasts to 2017" [http://www.researchandmarkets.com/research/d8qj9s/european ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) European Injectable Drug Delivery Market By Formulations [Liposomes, Microspheres, &...

2013-11-01 16:23:33

( ) PLAINSBORO, N.J., Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) has approved the prefilled insulin pens NovoLog(®) (insulin aspart [rDNA origin] injection) FlexTouch(®) and Levemir(®) (insulin detemir [rDNA origin] injection) FlexTouch(®). FlexTouch(®) is a new prefilled insulin delivery system from Novo Nordisk. To view the multimedia assets associated with this release, please click:...

2013-11-01 08:27:52

Contest raises $35,000 in donations to local diabetes-related organizations PLAINSBORO, N.J, Nov. 1, 2013 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, announced today that Walton Kelly from Thomaston, Georgia, is the grand prize winner of the NovoLog® Community Star contest. The contest was held earlier this year to recognize patients with type 2 diabetes who use NovoLog® (insulin aspart [rDNA origin] injection) to help manage their blood sugar and give back to their local...

2013-10-31 23:31:05

MarketResearch.com announces the addition of a new market research report in Pharmaceuticals to their product offering: Type 2 Diabetes Market to 2019 http://www.marketresearch.com/land/product.asp?productid=7840706&progid=85831. Rockville, MD (PRWEB) October 31, 2013 Type 2 Diabetes Therapeutics Market to 2019 - A Shifting Treatment Algorithm and Intensified Competition Expected to Drive Growth by 2019 The global type 2 diabetes market is expected to grow from $20.4 billion in 2012...